Clinical Trial Update: Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 trial update examining gradual initiation of sulfamethoxazole/trimethoprim as prophylaxis for Pneumocystis jirovecii pneumonia in HIV-infected individua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pneumocystis Pneumonia

Drugs mentioned

• Sulfamethoxazole-trimethoprim (sulfamethoxazole-trimethoprim)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 4 | Status: COMPLETED